Product Information

DYMISTA NASAL SPRAY is a brand product labeled by Viatris Specialty LLC, priced at $9.1402 per GM under NDC 00037024523. Its NADAC has been published 665 times since Nov 28, 2013.

FDA first approved this application on May 1, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the Azelastine Hydrochloride and Fluticasone Propionate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

Price Statistics

The NADAC for DYMISTA NASAL SPRAY has been published 665 times since Nov 28, 2013, and over the history we have for it it has risen 56.5%. The table below summarizes its recorded NADAC range and movement.

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 76% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.